Vargo to Become Emergent’s Interim CFO Jan. 1; Lindahl to Advise Through March 31

Frank Vargo will become Emergent BioSolutions’ interim chief financial officer on Jan. 1, 2027, as Richard Lindahl leaves the officer roles at year-end and stays on to guide the transition. Lindahl will leave the CFO and principal financial and accounting officer positions on Dec. 31, 2026. He will remain a senior executive adviser through March 31, 2027, when he is scheduled to retire. Vargo will assume both roles on Jan. 1. Lindahl’s advisory work will include helping prepare and file Emergent’s annual report on Form 10-K for the year ending Dec. 31, 2026.

Source: TokenPost